Report cover image

Genome Editing: Technologies and Global Markets

Publisher BCC Research
Published Jul 24, 2025
Length 117 Pages
SKU # WA20269851

Description

Report Scope

This report analyzes the market for genome editing technologies, applications and end users, offering insights into the market and technological trends. The study focuses on technologies such as CRISPR-Cas, transcription activator-like effector nucleases (TALEN) and zinc finger nucleases (ZFN), assessing their adoption in biopharmaceutical, agricultural biotech and research sectors. The market is segmented by applications into drug development, plant breeding, diagnostics and clinical therapy.

The report provides an analysis covering the regions of North America, Europe, Asia-Pacific and the Rest of the World (RoW), which includes Latin America, the Middle East and Africa. It evaluates the drivers, restraints, opportunities and challenges affecting the market and vendor landscape. It discusses clinical trials, patents and emerging technologies related to the market and looks at ESG-related developments.

The study offers an analysis of the competitive landscape, which ranks the top companies in the global market for genome editing. It also has a section with company profiles covering details of the market leaders. For market estimates, data has been provided for 2022 and 2023 as the historic years, 2024 as the base year, and forecasts for 2025 to 2030.

Report Includes
  • 52 data tables and 58 additional tables
  • A review of the global market for genome editing technologies
  • Analyses of the global market trends, with market revenue data from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030
  • Evaluation and forecast of the genome editing market, and a corresponding market share analysis by product, application, end user and geographic region
  • In-depth facts and figures concerning market drivers and deterrents, and other macroeconomic forces influencing the genome editing market
  • A look at the use of clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9, and how it has fueled the growth of the genome editing industry
  • An evaluation of the recent technological breakthroughs and issues, market regulations, and the current status of the intellectual property rights of the CRISPR-Cas9 genome editing technology
  • Review of patent trends and research publications in the global genome editing industry
  • Insight into the industry structure, competitive landscape, R&D activity, growth strategies and ESG trends
  • Identification of the companies best positioned to meet market demand due to their proprietary technologies, mergers and acquisitions, joint ventures and other strategic alliances
  • Profiles of the leading companies, including Merck KGaA, Thermo Fisher Scientific, Beam Therapeutics, CRISPR Therapeutics, and Cellectis S.A.

    Companies Mentioned

    Agilent Technologies Inc.
    Beam Therapeutics
    Caribou Biosciences Inc.
    Cellectis S.A.
    Crispr Therapeutics
    Editas Medicine
    Genscript
    Intellia Therapeutics Inc.
    Merck Kgaa
    Origene Technologies Inc.
    Precision Biosciences
    Sangamo Therapeutics
    Takara Bio Inc.
    Thermo Fisher Scientific Inc.
    Verve Therapeutics Inc.

Table of Contents

117 Pages
Chapter 1 Executive Summary
Market Outlook
Scope Of Report
Market Summary
Chapter 2 Market Overview
Overview And Market Definition
Macroeconomic Factors
Porter's Five Forces Model
Bargaining Power Of Buyers
Bargaining Power Of Suppliers
Potential For New Entrants
Competition In The Industry
Threat Of Substitutes
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Prevalence Of Genetic Disorders
New Genome-editing Technologies And Applications
Increasing Government And Private Funding
Market Restraints
Governmental Policies And Regulations
Ethical And Societal Concerns
Market Opportunities
Expanding Applications For Crispr Technology
Applications In Plant And Livestock Breeding
Market Challenges
Scalability Constraints In Gene Editing Workflows
Cost Of Crispr-based Therapy
Chapter 4 Regulatory Landscape
Regulatory Scenario, By Country/Region
North America
Eu
Asia-pacific
Rest Of The World
Chapter 5 Emerging Technologies And Developments
Emerging Technologies
In Vivo Delivery Of Crispr
Improved Cas Variants
Artificial Intelligence
Takeaways: Emerging Technologies In Crispr
Clinical Trials Analysis
Clinical Trials Analysis, By Type Of Study
Clinical Trials Analysis, By Status
Clinical Trials Analysis, By Phase
Selected Clinical Trials
Takeaways: Clinical Trials Landscape
Patent Analysis
Patents, By Year
Patents, By Leading Applicant
Patents, By Leading Patent Holder
Recent Patents Relating To Genome Editing Technology
Ip Disputes And Patent Issues
Key Takeaways: Patent Landscape (2020–2024)
Chapter 6 Market Segment Analysis
Segmentation Breakdown
Global Genome Editing Market, By Technology Type
Crispr-cas
Talen
Zfns
Other Genome Editing Platforms
Global Genome Editing Market, By Application
Drug Development
Plant Breeding
Diagnostics
Clinical Therapy
Other Applications
Global Genome Editing Market, By End User
Biopharmaceutical Companies
Agricultural Biotechnology
Research Institutions
Other End Users
Geographic Breakdown
Global Genome Editing Market, By Region
North America
Europe
Asia-pacific
Rest Of The World
Chapter 7 Competitive Intelligence
Market Ranking Analysis
Strategic Analysis
Final Takeaways
Chapter 8 Sustainability In The Genome Editing Market: Esg Perspective
Introduction To Esg
Sustainability In Genome Editing: An Esg Perspective
Esg Issues
Esg Performance Analysis
Environmental Performance
Social Performance
Governance Performance
Concluding Remarks From Bcc
Chapter 9 Appendix
Methodology
References
Abbreviations
Company Profiles
Agilent Technologies Inc.
Beam Therapeutics
Caribou Biosciences Inc.
Cellectis S.A.
Crispr Therapeutics
Editas Medicine
Genscript
Intellia Therapeutics Inc.
Merck Kgaa
Origene Technologies Inc.
Precision Biosciences
Sangamo Therapeutics
Takara Bio Inc.
Thermo Fisher Scientific Inc.
Verve Therapeutics Inc.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us